Keyphrases
Systemic Treatment
100%
Gallbladder Cancer
100%
T2 Gallbladder Cancer
100%
Biliary Tract Cancer
33%
Cholangiocarcinoma
33%
Treatment Options
16%
Clinical Trials
16%
Next-generation Sequencing
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Gemcitabine
16%
Palliation
16%
Cancer Clinical Trials
16%
Treatment Strategy
16%
Tumor Immunity
16%
Early Disease
16%
Immune Checkpoint Inhibitors
16%
Treatment Modalities
16%
Platinum-based Chemotherapy
16%
Treatment Paradigms
16%
Highly Aggressive
16%
Targeted Therapeutics
16%
Genetic mutation
16%
Chemotherapeutic Strategies
16%
Driver mutations
16%
Intrahepatic Cholangiocarcinoma (iCCA)
16%
Graves
16%
Rare Cancer
16%
Complete Surgical Resection
16%
Upfront Chemotherapy
16%
Emerging Treatments
16%
Unresectable Locally Advanced
16%
Extrahepatic Cholangiocarcinoma
16%
Medicine and Dentistry
Systemic Therapy
100%
Gallbladder Cancer
100%
Cholangiocarcinoma
50%
Clinical Trial
25%
Biliary Duct Cancer
25%
Malignant Neoplasm
12%
Clinical Study
12%
Gene Mutation
12%
Symptomatic Treatment
12%
Next Generation Sequencing
12%
Immune Checkpoint Inhibitor
12%
Gemcitabine
12%
Emerging Treatment
12%
Surgery
12%
Diseases
12%
Chemotherapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Treatment
100%
Gallbladder Cancer
100%
Bile Duct Carcinoma
50%
Clinical Trial
25%
Chemotherapy
25%
Biliary Tract Cancer
25%
Malignant Neoplasm
12%
Clinical Study
12%
Gemcitabine
12%
Immune Checkpoint Inhibitor
12%
Diseases
12%